Third Pole, Inc.

Third Pole Therapeutics is a biotech company reimagining heart and lung therapy. It develops next‑generation therapeutics and delivery approaches aimed at repairing and regenerating cardiopulmonary tissue to address heart failure and chronic lung disease. The company focuses on translating advanced biology into clinical candidates and works with clinicians and partners to move therapies from preclinical development toward trials and commercialization.